Independent information service. We do not sell, ship, supply or prescribe medicines.
Drug database
Oncology treatments approved in China, with US and EU status alongside so you can see the gap at a glance.
Coverage currently focuses on lung cancer and haematologic malignancies.
0 entries shown. Data last reviewed .
Drug
Target
Cancer type
China (NMPA)
US / EU status
Company
Availability
Spot something wrong? Regulatory status changes every quarter — drugs get approved, licensed globally, or withdrawn.
If you see an entry that is out of date, please tell us. We publish a correction note and the date it was fixed.